Urogen Pharma Ltd (URGN)

Other Income/Expenses (Net)

-$8.83M

Quarterly · Period ending: · USD

URGN logo

URGN Other Income/Expenses (Net)

Latest reported-$8.83M
URGN Quarterly Other Income/Expenses (Net) (-$6.00K → -$8.83M)
High-resolution chart · PNG

URGN other income/expenses (net) history

Quarterly · USD. Dates are reporting period ends; fiscal years can differ from calendar years.

Urogen Pharma Ltd Other Income/Expenses (Net) — Quarterly (USD)
Period endingOther Income/Expenses (Net) (USD)
-8,833,000
-8,083,000
-7,524,000
-7,015,000
-7,477,000
-6,537,000
-7,205,000
-6,037,000
-7,526,000
-6,492,000
-7,553,000
-8,388,000
-8,700,000
-8,147,000
-7,898,000
-7,035,000
-7,944,000
-6,110,000
-7,400,000
-6,771,000
-3,087,000
179,000
102,000
308,000
451,000
768,000
866,000
1,201,000
1,276,000
989,000
425,000
556,000
408,000
258,000
91,000
5,000
-248,000
121,000
-978,000
-1,877,000
78,000
38,000
-74,000
-11,001
-6,000
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.